Celldex Therapeutics, Inc. (NASDAQ:CLDX) Shares Sold by First Trust Advisors LP

First Trust Advisors LP trimmed its holdings in shares of Celldex Therapeutics, Inc. (NASDAQ:CLDX – Free Report) by 50.9% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 18,372 shares of the biopharmaceutical company’s sto…

Read Full Article →